vs
林德（LIN）与辉瑞（PFE）财务数据对比。点击上方公司名可切换其他公司
辉瑞的季度营收约是林德的1.6倍（$14.5B vs $8.8B），林德同比增速更快（8.2% vs 5.0%），过去两年辉瑞的营收复合增速更高（4.3% vs 3.1%）
林德是全球知名跨国化工企业，按市场份额及营收计为全球最大工业气体供应商。公司1879年由德国科学家、工程师卡尔·冯·林德在德国威斯巴登创立，现总部位于英国沃金，在爱尔兰注册，2018年由原林德股份公司与1907年在美国成立的普莱克斯合并组建。
辉瑞是总部位于美国纽约曼哈顿The Spiral的跨国制药及生物技术企业，由德国企业家查尔斯·辉瑞与查尔斯·F·埃尔哈特于1849年在纽约创立，是北美地区历史最悠久的制药企业之一，在全球医药健康领域拥有较高的行业影响力。
LIN vs PFE — 直观对比
营收规模更大
PFE
是对方的1.6倍
$8.8B
营收增速更快
LIN
高出3.2%
5.0%
两年增速更快
PFE
近两年复合增速
3.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $8.8B | $14.5B |
| 净利润 | — | $2.7B |
| 毛利率 | 48.5% | — |
| 营业利润率 | 27.8% | — |
| 净利率 | — | 18.6% |
| 营收同比 | 8.2% | 5.0% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $3.98 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LINPFE
| Q1 26 | $8.8B | $14.5B | ||
| Q4 25 | $8.8B | $17.6B | ||
| Q3 25 | $8.6B | $16.7B | ||
| Q2 25 | $8.5B | $14.7B | ||
| Q1 25 | $8.1B | $13.7B | ||
| Q4 24 | $8.3B | $17.8B | ||
| Q3 24 | $8.4B | $17.7B | ||
| Q2 24 | $8.3B | $13.3B |
净利润LINPFE
| Q1 26 | — | $2.7B | ||
| Q4 25 | $1.5B | $-1.6B | ||
| Q3 25 | $1.9B | $3.5B | ||
| Q2 25 | $1.8B | $2.9B | ||
| Q1 25 | $1.7B | $3.0B | ||
| Q4 24 | $1.7B | $410.0M | ||
| Q3 24 | $1.6B | $4.5B | ||
| Q2 24 | $1.7B | $41.0M |
毛利率LINPFE
| Q1 26 | 48.5% | — | ||
| Q4 25 | — | 70.0% | ||
| Q3 25 | — | 74.9% | ||
| Q2 25 | — | 74.2% | ||
| Q1 25 | — | 79.3% | ||
| Q4 24 | — | 66.7% | ||
| Q3 24 | — | 70.3% | ||
| Q2 24 | — | 75.2% |
营业利润率LINPFE
| Q1 26 | 27.8% | — | ||
| Q4 25 | 23.0% | -9.4% | ||
| Q3 25 | 27.5% | 20.0% | ||
| Q2 25 | 27.7% | 20.8% | ||
| Q1 25 | 26.9% | 20.3% | ||
| Q4 24 | 27.4% | -0.1% | ||
| Q3 24 | 25.0% | 26.6% | ||
| Q2 24 | 26.4% | -0.8% |
净利率LINPFE
| Q1 26 | — | 18.6% | ||
| Q4 25 | 17.5% | -9.4% | ||
| Q3 25 | 22.4% | 21.3% | ||
| Q2 25 | 20.8% | 19.9% | ||
| Q1 25 | 20.6% | 21.6% | ||
| Q4 24 | 20.8% | 2.3% | ||
| Q3 24 | 18.5% | 25.2% | ||
| Q2 24 | 20.1% | 0.3% |
每股收益（稀释后）LINPFE
| Q1 26 | $3.98 | $0.47 | ||
| Q4 25 | $3.28 | $-0.29 | ||
| Q3 25 | $4.09 | $0.62 | ||
| Q2 25 | $3.73 | $0.51 | ||
| Q1 25 | $3.51 | $0.52 | ||
| Q4 24 | $3.61 | $0.07 | ||
| Q3 24 | $3.22 | $0.78 | ||
| Q2 24 | $3.44 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0B | — |
| 总债务越低越好 | $24.7B | — |
| 股东权益账面价值 | $40.1B | — |
| 总资产 | $86.3B | — |
| 负债/权益比越低杠杆越低 | 0.62× | — |
8季度趋势，按日历期对齐
现金及短期投资LINPFE
| Q1 26 | $4.0B | — | ||
| Q4 25 | $5.1B | $1.1B | ||
| Q3 25 | $4.5B | $1.3B | ||
| Q2 25 | $4.8B | $1.6B | ||
| Q1 25 | $5.3B | $1.4B | ||
| Q4 24 | $4.8B | $1.0B | ||
| Q3 24 | $5.2B | $1.1B | ||
| Q2 24 | $4.6B | $1.1B |
总债务LINPFE
| Q1 26 | $24.7B | — | ||
| Q4 25 | $20.7B | — | ||
| Q3 25 | $18.6B | — | ||
| Q2 25 | $19.7B | — | ||
| Q1 25 | $17.6B | — | ||
| Q4 24 | $15.3B | — | ||
| Q3 24 | $17.5B | — | ||
| Q2 24 | $16.9B | — |
股东权益LINPFE
| Q1 26 | $40.1B | — | ||
| Q4 25 | $38.2B | $86.5B | ||
| Q3 25 | $38.6B | $92.8B | ||
| Q2 25 | $38.5B | $88.7B | ||
| Q1 25 | $38.0B | $90.3B | ||
| Q4 24 | $38.1B | $88.2B | ||
| Q3 24 | $39.2B | $92.3B | ||
| Q2 24 | $38.2B | $87.7B |
总资产LINPFE
| Q1 26 | $86.3B | — | ||
| Q4 25 | $86.8B | $208.2B | ||
| Q3 25 | $86.0B | $208.7B | ||
| Q2 25 | $86.1B | $206.1B | ||
| Q1 25 | $82.7B | $208.0B | ||
| Q4 24 | $80.1B | $213.4B | ||
| Q3 24 | $82.5B | $219.5B | ||
| Q2 24 | $80.2B | $216.2B |
负债/权益比LINPFE
| Q1 26 | 0.62× | — | ||
| Q4 25 | 0.54× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | 0.44× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | $898.0K | — |
| 自由现金流率自由现金流/营收 | 0.0% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.2B | — |
8季度趋势，按日历期对齐
经营现金流LINPFE
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $5.3B | ||
| Q3 25 | $2.9B | $4.6B | ||
| Q2 25 | $2.2B | $-582.0M | ||
| Q1 25 | $2.2B | $2.3B | ||
| Q4 24 | $2.8B | $6.7B | ||
| Q3 24 | $2.7B | $6.7B | ||
| Q2 24 | $1.9B | $-1.8B |
自由现金流LINPFE
| Q1 26 | $898.0K | — | ||
| Q4 25 | $1.6B | $4.5B | ||
| Q3 25 | $1.7B | $4.0B | ||
| Q2 25 | $954.0M | $-1.2B | ||
| Q1 25 | $891.0M | $1.8B | ||
| Q4 24 | $1.6B | $5.8B | ||
| Q3 24 | $1.7B | $6.1B | ||
| Q2 24 | $796.0M | $-2.4B |
自由现金流率LINPFE
| Q1 26 | 0.0% | — | ||
| Q4 25 | 17.9% | 25.6% | ||
| Q3 25 | 19.4% | 24.0% | ||
| Q2 25 | 11.2% | -8.2% | ||
| Q1 25 | 11.0% | 12.9% | ||
| Q4 24 | 18.8% | 32.7% | ||
| Q3 24 | 19.9% | 34.3% | ||
| Q2 24 | 9.6% | -18.2% |
资本支出强度LINPFE
| Q1 26 | — | — | ||
| Q4 25 | 16.6% | 4.8% | ||
| Q3 25 | 14.8% | 3.6% | ||
| Q2 25 | 14.8% | 4.2% | ||
| Q1 25 | 15.7% | 4.1% | ||
| Q4 24 | 15.1% | 5.2% | ||
| Q3 24 | 12.8% | 3.7% | ||
| Q2 24 | 13.7% | 4.8% |
现金转化率LINPFE
| Q1 26 | — | — | ||
| Q4 25 | 1.98× | — | ||
| Q3 25 | 1.53× | 1.30× | ||
| Q2 25 | 1.25× | -0.20× | ||
| Q1 25 | 1.29× | 0.79× | ||
| Q4 24 | 1.63× | 16.39× | ||
| Q3 24 | 1.76× | 1.50× | ||
| Q2 24 | 1.16× | -43.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIN
暂无分部数据
PFE
| Product revenues | $11.7B | 81% |
| Alliance revenues | $2.3B | 16% |
| Royalty revenues | $396.0M | 3% |
